Matches 1 - 50 out of 79 1 2 >


Match Document Document Title
US20140302141 Triple Combination Release Multi-layered Tablet  
This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet...
US20140335178 DOSAGE FORMS OF APIXABAN  
The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for...
US20140030330 DOSAGE FORMS OF APIXABAN  
The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for...
US20120070496 ANTIDEPRESSANT DOSAGE FORM  
A dosage form having sustained-release or controlled-release properties for delivering 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-cyclohexanol from the dosage form over an extended period of...
US20130259941 CONTROLLED RELEASE DOSAGE FORMS  
Dosage forms having a core having a surface having means for controlling release(s) on an active agent(s); methods of manufacturing, tools used in manufacturing; and uses of the dosage forms are...
US20140271842 TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS  
The present invention relates to oral sustained release formulations of tofacitinib and pharmaceutical acceptable salts thereof. The formulations described herein have desirable pharmacokinetic...
US20130209562 METHODS AND DEVICES FOR PROVIDING PROLONGED DRUG THERAPY  
Methods and devices for maintaining a desired therapeutic drug effect over a prolonged therapy period are provided. In particular, oral dosage forms that release drug within the gastrointestinal...
US20120301547 PALIPERIDONE DOUBLE-LAYERED OSMOTIC PUMP CONTROLLED RELEASE TABLET AND PREPARATION METHOD THEREOF  
A paliperidone double-layered osmotic pump controlled release tablet and the preparation method thereof are disclosed. The double-layered osmotic pump controlled release tablet comprises a rigid...
US20130287850 FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES  
Controlled release formulations and methods for preparing controlled release formulations for delivery of active drug substances are described herein. The formulations described herein may be...
US20130287849 FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES  
Controlled release formulations and methods for preparing controlled release formulations for delivery of active drug substances are described herein. The formulations described herein may be...
US20060165798 Oral osmotic dosage form having a high flux membrane  
Disclosed are oral osmotic dosage forms and methods wherein a semi-permeable membrane of the oral osmotic dosage form includes from about 23 wt % to about 50 wt % of a flux enhancer and from about...
US20070009600 Antidepressant dosage form  
The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
US20050136112 Oral medicament delivery system  
Oral medicament delivery system comprising a pharmaceutical composition comprising a flexible matrix, said matrix formed of a plurality of fibers comprising a collagen-based carrier and a...
US20070201024 METHOD AND APPARATUS FOR SEMI-PERMEABLE MEMBRANE DETECTION ON OSMOTIC TABLETS INCORATING NEAR-INFRARED SPECTROSCOPY  
Disclosed are apparatus and methods relating to the manufacture of osmotic tablets, in particular to the use of near-infrared spectroscopy in the detection of the presence or absence of...
US20070231390 Formulations including hygroscopic compounds  
The invention is directed to dosage forms suitable for the administration of hygroscopic active agents.
US20060153918 Dosage forms with an enterically coated core tablet  
The present invention provides a pharmaceutical dosage form for oral administration to a patient comprising an enterically coated core tablet sheathed in an annular body of compressed powder or...
US20050281876 Solid dosage form for acid-labile active ingredient  
The present invention relates to solid, orally administrable dosage forms for acid-labile actives having at least one molded insert or core containing an acid-labile active ingredient, such as a...
US20050196448 Polymeric compositions and dosage forms comprising the same  
A dosage form comprises: (a) at least one active ingredient; (b) a core having an outer surface; and (c) a shell which resides upon at least a portion of the core outer surface, wherein at least a...
US20050048119 Controlled release composition with semi-permeable membrane and poloxamer flux enhancer  
A controlled release pharmaceutical tablet comprising a core containing the antihyperglycemic drug, a water soluble seal coat, a semipermeable membrane coating the core and at least one passageway...
US20050175701 Capillary moderator for osmotic delivery system  
The present invention relates to apparatus and methods for preventing backflow into a beneficial agent dispensing osmotic delivery system.
US20070077301 Venlafaxine osmotic device formulation  
The present invention provides an osmotic device containing controlled release venlafaxine in the core, wherein the osmotic device exhibits a reduced food effect as compared to a reference...
US20050129764 Osmotic device containing licofelone  
The present invention provides an osmotic device containing controlled release licofelone and, optionally, a rapid release licofelone in an external coat. The osmotic devices provide a controlled...
US20050163850 Administration of levodopa and carbidopa  
Disclosed are substances, compositions, dosage forms and methods that comprise levodopa and/or carbidopa.
US20070166373 Pre-fabricated semi-permeable capsule shells containing a semipermeable layer on a water-dispersible/soluble gelatinous shell for osmotic drug delivery system  
The present invention is centered on the design, manufacturing and use of a novel capsule system made up of a bi- or multi-layered two piece capsule shell made of a water soluble/dispersible layer...
US20080299197 Triple Combination Release Multi-Layered Tablet  
This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet...
US20060159763 Osmotic device containing amantadine and an osmotic salt  
The osmotic devices of the present invention contain a unitary core comprising a salt of amantadine and an osmotic salt, wherein the two salts have an ion in common. The release rate of the...
US20050287214 Squeeze controlled oral dosage form  
A controlled release dosage form includes an active agent composition and a squeeze layer circumscribing at least a portion of the active agent composition. The squeeze layer includes a material...
US20080003287 Extended release perforated tablet  
A tablet for the controlled release of a pharmaceutically active ingredient. The tablet is in the form of coated DST's and MLDST's so that immediate release or time-delayed release can be...
US20100272793 Controlled Release Hydraliazine Formulations  
The invention is for a method and composition for preparing a controlled release pharmaceutical formulation which can be used to administer Hydralazine hydrochloride over a 24 hours time frame,...
US20060233882 Osmotic dosage form  
The present invention is directed to a modified release dosage form for delivering at least one pharmaceutically active ingredient. The dosage form has a first immediate release core for an active...
US20070003624 Semi-permeable compositions providing reduced drying time for osmotic dosage forms  
Disclosed are methods including providing an osmotic core; coating the osmotic core with a coating composition that comprises cellulose acetate butyrate; drying the coated osmotic core for a...
US20100143472 OSMOTIC FORM FOR CONTROLLED RELEASE OF ACTIVE PRINCIPLES  
The present invention refers to a tablet-shaped osmotic release system providing, in a controlled way, active principles which solubility depends on the pH of the medium, simultaneously providing...
US20070031496 Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties  
Disclosed are osmotic dosage forms including an osmotic core; a semi-permeable membrane that surrounds the osmotic core and comprises a blend of a cellulose acetate polymer and an acrylate...
US20070196487 METHOD AND APPARATUS FOR DRILLING ORIFICES IN OSMOTIC TABLETS INCORPORATING NEAR-INFRARED SPECTROSCOPY  
The present invention relates to apparatus and methods for the manufacture of osmotic tablets, wherein near-infrared spectroscopy systems are used.
US20050008702 Rupturing controlled release device having a preformed passageway  
The present invention provides a simple and improved osmotic device that is capable of providing a controlled release of active agent contained in the core first through a preformed passageway and...
US20070184099 Films for use as dosage forms  
Non gelatin film materials e.g. films of modified cellulose materials find use as dosage forms. Substances are incorporated into the film matrix and films thus prepared may be administered really,...
US20050042291 Diffusion layer modulated solids  
Diffusion layer modulated solids that include an excipient and a soluble salt of a poorly soluble, basic drug; a soluble salt of a poorly soluble, acidic drug; or a poorly soluble, non-ionizable...
US20060210633 Programmed drug delivery system  
The present invention provides a programmed drug delivery system comprising: (a) a core composition comprising one or more beneficial agents and pharmaceutically acceptable excipients, wherein at...
US20070110808 Extended release osmo-microsealed formulation  
The extended release osmo-microsealed formulation includes three controlled release systems associated in series. First, there is an inner solid particulate phase containing Venlafaxine...
US20060204578 Dual controlled release dosage form  
A dosage form that provides a controlled release of at least two different active agents is provided. Particular embodiments include a dosage form that provides therapeutically effective levels of...
US20060257484 Combination of tramadol and substances that comprise gabapentin  
Disclosed are substances, compositions, dosage forms and methods that comprise tramadol and substances that comprise gabapentin.
US20050287213 Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents  
An osmotic controlled release dosage form is described comprising a core comprising a first drug composition, wherein the first drug composition comprises topiramate and/or its pharmaceutically...
US20050048120 Dosage form comprising self-destructive membrane  
A sustained release dosage form is disclosed, which dosage form comprises an interior lipophilic membrane, and an exterior hydrophilic membrane comprising a peptide, that surround a composition...
US20050175700 Oral dosage form for controlled drug release  
An oral dosage form comprising, (i) an erodable core, which core comprises a pharmaceutically active weak base or a pharmaceutically acceptable salt or solvate thereof; and (ii) an erodable...
US20060057206 Controlled release nanoparticle active agent formulation dosage forms and methods  
Controlled release of self-dispersing nanoparticle active agent formulations is provided by dispersing porous particles into which have been sorbed a self-dispersing nanoparticle active agent...
US20050129765 Controlled release of topiramate in liquid dosage forms  
This invention relates to novel formulations and methods for the controlled release delivery of topiramate; as well as to the use of these formulations and methods for treating disease.
US20070259033 Controlled release formulations exhibiting an ascending rate of release  
A sustained release dosage form is comprising a pharmaceutically active agent and pharmaceutically acceptable salts thereof and adapted to release as an erodible solid over a prolonged period of...
US20070014858 Method for controlling lag time of in-situ passageway formation in osmotic delivery system  
An osmotically controlled delivery system includes a solid core having a shallow indentation on a surface of the core, and a semipermeable membrane enclosing the solid core. The solid core is made...
US20060105040 Pharmaceutical tablet and process for making thereof  
A pharmaceutical tablet as well as a process for manufacturing the tablet are described herein. More specifically, a tablet and process of manufacture is described where a drug having a defined...
US20070281024 Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator  
An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a...

Matches 1 - 50 out of 79 1 2 >